Your browser doesn't support javascript.
Prevalence of chronic conditions and multimorbidity in Estonia: a population-based cross-sectional study.
Jürisson, Mikk; Pisarev, Heti; Uusküla, Anneli; Lang, Katrin; Oona, M; Kalda, Ruth.
  • Jürisson M; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia mikkjurisson@gmail.com.
  • Pisarev H; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
  • Uusküla A; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
  • Lang K; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
  • Oona M; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
  • Kalda R; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
BMJ Open ; 11(10): e049045, 2021 10 05.
Article in English | MEDLINE | ID: covidwho-1462957
ABSTRACT

OBJECTIVES:

Prevalence estimates for specific chronic conditions and multimorbidity (MM) in eastern Europe are scarce. This national study estimates the prevalence of MM by age group and sex in Estonia.

DESIGN:

A population-based cross-sectional study, using administrative data.

SETTING:

Data were collected on 55 chronic conditions from the Estonian Health Insurance Fund from 2015 to 2017. MM was defined as the coexistence of two or more conditions.

PARTICIPANTS:

The Estonian Health Insurance Fund includes data for approximately 95% of the Estonian population receiving public health insurance. PRIMARY AND SECONDARY OUTCOME

MEASURES:

Prevalence and 95% CIs for MM stratified by age group and sex.

RESULTS:

Nearly half (49.1%) of the individuals (95% CI 49.0 to 49.3) had at least 1 chronic condition, and 30.1% (95% CI 30.0 to 30.2) had MM (2 or more chronic conditions). The number of conditions and the prevalence of MM increased with age, ranging from an MM prevalence of 3.5% (3.5%-3.6%) in the youngest (0-24 years) to as high as 80.4% (79.4%-81.3%) in the oldest (≥85 years) age group. Half of all individuals had MM by 60 years of age, and 75% of the population had MM by 75 years of age. Women had a higher prevalence of MM (34.9%, 95% CI 34.7 to 35.0) than men (24.4%, 95% CI 24.3 to 24.5). Hypertension was the most frequent chronic condition (24.5%), followed by chronic pain (12.4%) and arthritis (7.7%).

CONCLUSIONS:

Hypertension is an important chronic condition amenable to treatment with lifestyle and therapeutic interventions. Given the established correlation between uncontrolled hypertension and exacerbation of other cardiovascular conditions as well as acute illnesses, this most common condition within the context of MM may be suitable for targeted public health interventions.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Multimorbidity Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Infant, Newborn / Young adult Country/Region as subject: Europa Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-049045

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Multimorbidity Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Infant, Newborn / Young adult Country/Region as subject: Europa Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-049045